Alexza Pharmaceuticals Inc (NASDAQ:ALXA)

CAPS Rating: 2 out of 5

An emerging pharmaceutical company focused on the development and commercialization of novel, proprietary products for the treatment of acute and intermittent conditions.


Player Avatar scottedont (65.16) Submitted: 11/5/2008 9:26:27 PM : Underperform Start Price: $20.00 ALXA Score: +180.31

This is a sinking ship. This stock has been shot by freakin' sharks that have freakin' laser beams attached to their freakin' heads.

Featured Broker Partners